Revisión
El rechazo en las transfusiones de sangre y hemoderivados: criterios éticos, deontológicos y médico-legales
Refusal of blood or blood-products transfusions: ethical, deontological and medico-legal criteria
Marius Morlansa,
, Dolors Clos-Masób, Esperanza-L. Gómez-Duránb,c,d, Josep Arimany-Mansob,e
Autor para correspondencia
a Comisión Deontológica, Colegio de Médicos de Barcelona, Barcelona, España
b Servei de Responsabilitat Professional, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Cataluña, Barcelona, España
c Departamento de Medicina, Universitat Internacional de Catalunya, Barcelona, España
d Servicio de Psiquiatría, Fundació Sociosanitària de Barcelona, Barcelona, España
e Unidad de Medicina Legal, Facultad de Medicina, Universitat de Barcelona, Barcelona, España
Leído
8835
Vecesse ha leído el artículo
1391
Total PDF
7444
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 6 | 6 |
| 2025 11 | 1 | 22 | 23 |
| 2025 10 | 0 | 3 | 3 |
| 2025 9 | 1 | 8 | 9 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 3 | 3 |
| 2025 6 | 0 | 5 | 5 |
| 2025 5 | 0 | 6 | 6 |
| 2025 4 | 0 | 12 | 12 |
| 2025 3 | 0 | 3 | 3 |
| 2025 2 | 0 | 1 | 1 |
| 2024 12 | 0 | 4 | 4 |
| 2024 11 | 0 | 5 | 5 |
| 2024 9 | 0 | 1 | 1 |
| 2024 8 | 0 | 2 | 2 |
| 2024 6 | 0 | 1 | 1 |
| 2024 5 | 0 | 1 | 1 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 1 | 1 |
| 2024 2 | 0 | 2 | 2 |
| 2024 1 | 0 | 4 | 4 |
| 2023 11 | 0 | 3 | 3 |
| 2023 10 | 0 | 4 | 4 |
| 2023 9 | 0 | 3 | 3 |
| 2023 8 | 1 | 0 | 1 |
| 2023 7 | 0 | 2 | 2 |
| 2023 6 | 0 | 6 | 6 |
| 2023 5 | 0 | 11 | 11 |
| 2023 4 | 0 | 7 | 7 |
| 2023 3 | 14 | 6 | 20 |
| 2023 2 | 0 | 9 | 9 |
| 2022 1 | 0 | 6 | 6 |
| 2022 12 | 0 | 6 | 6 |
| 2022 11 | 3 | 6 | 9 |
| 2022 10 | 5 | 8 | 13 |
| 2022 9 | 4 | 8 | 12 |
| 2022 8 | 0 | 1 | 1 |
| 2022 7 | 0 | 5 | 5 |
| 2022 6 | 0 | 5 | 5 |
| 2022 5 | 0 | 33 | 33 |
| 2022 4 | 0 | 42 | 42 |
| 2022 3 | 0 | 52 | 52 |
| 2022 2 | 0 | 39 | 39 |
| 2021 1 | 1 | 50 | 51 |
| 2021 12 | 0 | 45 | 45 |
| 2021 11 | 0 | 38 | 38 |
| 2021 10 | 0 | 28 | 28 |
| 2021 9 | 0 | 46 | 46 |
| 2021 8 | 0 | 22 | 22 |
| 2021 7 | 0 | 8 | 8 |
| 2021 6 | 0 | 4 | 4 |
| 2021 5 | 1 | 9 | 10 |
| 2021 4 | 0 | 8 | 8 |
| 2021 3 | 0 | 14 | 14 |
| 2021 2 | 0 | 4 | 4 |
| 2020 1 | 0 | 3 | 3 |
| 2020 12 | 1 | 4 | 5 |
| 2020 11 | 1 | 14 | 15 |
| 2020 10 | 0 | 2 | 2 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 2 | 2 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 4 | 4 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 5 | 5 |
| 2020 2 | 0 | 2 | 2 |
| 2020 1 | 0 | 4 | 4 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 4 | 4 |
| 2019 9 | 0 | 4 | 4 |
| 2019 7 | 0 | 6 | 6 |
| 2019 6 | 0 | 4 | 4 |
| 2019 5 | 1 | 21 | 22 |
| 2019 4 | 0 | 7 | 7 |
| 2019 2 | 1 | 2 | 3 |
| 2018 11 | 1 | 0 | 1 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 98 | 3 | 101 |
| 2018 4 | 377 | 9 | 386 |
| 2018 3 | 241 | 5 | 246 |
| 2018 2 | 223 | 7 | 230 |
| 2018 1 | 105 | 2 | 107 |
| 2017 12 | 162 | 4 | 166 |
| 2017 11 | 251 | 4 | 255 |
| 2017 10 | 299 | 13 | 312 |
| 2017 9 | 284 | 5 | 289 |
| 2017 8 | 229 | 12 | 241 |
| 2017 7 | 162 | 1 | 163 |
| 2017 6 | 327 | 24 | 351 |
| 2017 5 | 271 | 19 | 290 |
| 2017 4 | 263 | 5 | 268 |
| 2017 3 | 333 | 16 | 349 |
| 2017 2 | 371 | 13 | 384 |
| 2016 1 | 195 | 5 | 200 |
| 2016 12 | 180 | 15 | 195 |
| 2016 11 | 307 | 10 | 317 |
| 2016 10 | 361 | 13 | 374 |
| 2016 9 | 319 | 35 | 354 |
| 2016 8 | 207 | 25 | 232 |
| 2016 7 | 134 | 13 | 147 |
| 2016 6 | 129 | 22 | 151 |
| 2016 5 | 157 | 22 | 179 |
| 2016 4 | 130 | 23 | 153 |
| 2016 3 | 129 | 25 | 154 |
| 2016 2 | 131 | 43 | 174 |
| 2015 1 | 110 | 26 | 136 |
| 2015 12 | 81 | 25 | 106 |
| 2015 11 | 160 | 24 | 184 |
| 2015 10 | 171 | 35 | 206 |
| 2015 9 | 72 | 22 | 94 |
| 2015 8 | 100 | 24 | 124 |
| 2015 7 | 123 | 22 | 145 |
| 2015 6 | 59 | 25 | 84 |
| 2015 5 | 68 | 29 | 97 |
| 2015 4 | 85 | 39 | 124 |
| 2015 3 | 1 | 0 | 1 |
| 2015 2 | 1 | 1 | 2 |
| 2015 1 | 1 | 0 | 1 |
Mostrar todo